Annual Net Income
-$184.68 M
-$3.56 M-1.97%
31 December 2023
Summary:
Rhythm Pharmaceuticals annual net profit is currently -$184.68 million, with the most recent change of -$3.56 million (-1.97%) on 31 December 2023. During the last 3 years, it has fallen by -$50.68 million (-37.82%). RYTM annual net income is now -1567.82% below its all-time high of -$11.07 million, reached on 31 December 2015.RYTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$43.64 M
-$11.38 M-35.27%
30 September 2024
Summary:
Rhythm Pharmaceuticals quarterly net profit is currently -$43.64 million, with the most recent change of -$11.38 million (-35.27%) on 30 September 2024. Over the past year, it has increased by +$522.00 thousand (+1.18%). RYTM quarterly net income is now -199.75% below its all-time high of $43.75 million, reached on 31 March 2021.RYTM Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$258.91 M
+$522.00 K+0.20%
30 September 2024
Summary:
Rhythm Pharmaceuticals TTM net profit is currently -$258.91 million, with the most recent change of +$522.00 thousand (+0.20%) on 30 September 2024. Over the past year, it has dropped by -$73.37 million (-39.54%). RYTM TTM net income is now -3951.12% below its all-time high of -$6.39 million, reached on 30 September 2016.RYTM TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RYTM Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -2.0% | +1.2% | -39.5% |
| 3 y3 years | -37.8% | -24.3% | -320.0% |
| 5 y5 years | -149.3% | -21.2% | -94.3% |
RYTM Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -165.3% | at low | -35.3% | +69.1% | -320.0% | +5.5% |
| 5 y | 5 years | -165.3% | at low | -199.8% | +69.1% | -361.7% | +5.5% |
| alltime | all time | -1567.8% | at low | -199.8% | +69.1% | -3951.1% | +5.5% |
Rhythm Pharmaceuticals Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$43.64 M(+35.3%) | -$258.91 M(-0.2%) |
| June 2024 | - | -$32.26 M(-77.2%) | -$259.43 M(-5.3%) |
| Mar 2024 | - | -$141.37 M(+239.6%) | -$273.87 M(+48.3%) |
| Dec 2023 | -$184.68 M(+2.0%) | -$41.63 M(-5.7%) | -$184.68 M(-0.5%) |
| Sept 2023 | - | -$44.16 M(-5.4%) | -$185.54 M(+1.8%) |
| June 2023 | - | -$46.70 M(-10.5%) | -$182.24 M(+0.9%) |
| Mar 2023 | - | -$52.18 M(+22.8%) | -$180.53 M(-0.3%) |
| Dec 2022 | -$181.12 M(+160.2%) | -$42.49 M(+4.0%) | -$181.12 M(-0.2%) |
| Sept 2022 | - | -$40.86 M(-9.2%) | -$181.49 M(+3.3%) |
| June 2022 | - | -$45.00 M(-14.7%) | -$175.74 M(+5.8%) |
| Mar 2022 | - | -$52.76 M(+23.1%) | -$166.13 M(+138.6%) |
| Dec 2021 | -$69.61 M(-48.0%) | -$42.87 M(+22.1%) | -$69.61 M(+12.9%) |
| Sept 2021 | - | -$35.11 M(-0.8%) | -$61.64 M(+2.1%) |
| June 2021 | - | -$35.39 M(-180.9%) | -$60.35 M(+7.6%) |
| Mar 2021 | - | $43.75 M(-225.4%) | -$56.08 M(-58.1%) |
| Dec 2020 | -$134.00 M | -$34.90 M(+3.2%) | -$134.00 M(+1.5%) |
| Sept 2020 | - | -$33.82 M(+8.7%) | -$132.06 M(-1.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2020 | - | -$31.12 M(-8.9%) | -$134.24 M(-8.0%) |
| Mar 2020 | - | -$34.16 M(+3.7%) | -$145.92 M(+3.7%) |
| Dec 2019 | -$140.73 M(+90.0%) | -$32.96 M(-8.5%) | -$140.73 M(+5.6%) |
| Sept 2019 | - | -$36.00 M(-15.9%) | -$133.28 M(+15.9%) |
| June 2019 | - | -$42.80 M(+47.7%) | -$114.96 M(+32.8%) |
| Mar 2019 | - | -$28.97 M(+13.6%) | -$86.58 M(+16.9%) |
| Dec 2018 | -$74.06 M(+119.7%) | -$25.51 M(+44.2%) | -$74.06 M(+25.3%) |
| Sept 2018 | - | -$17.69 M(+22.7%) | -$59.09 M(+14.9%) |
| June 2018 | - | -$14.41 M(-12.4%) | -$51.42 M(+17.4%) |
| Mar 2018 | - | -$16.46 M(+56.3%) | -$43.81 M(+30.0%) |
| Dec 2017 | -$33.71 M(+30.3%) | -$10.53 M(+5.1%) | -$33.71 M(+6.9%) |
| Sept 2017 | - | -$10.02 M(+47.3%) | -$31.54 M(+13.0%) |
| June 2017 | - | -$6.80 M(+6.9%) | -$27.92 M(+32.2%) |
| Mar 2017 | - | -$6.36 M(-24.0%) | -$21.12 M(+43.1%) |
| Dec 2016 | -$25.87 M(+133.6%) | -$8.37 M(+30.9%) | -$14.76 M(+130.9%) |
| Sept 2016 | - | -$6.39 M | -$6.39 M |
| Dec 2015 | -$11.07 M | - | - |
FAQ
- What is Rhythm Pharmaceuticals annual net profit?
- What is the all time high annual net income for Rhythm Pharmaceuticals?
- What is Rhythm Pharmaceuticals annual net income year-on-year change?
- What is Rhythm Pharmaceuticals quarterly net profit?
- What is the all time high quarterly net income for Rhythm Pharmaceuticals?
- What is Rhythm Pharmaceuticals quarterly net income year-on-year change?
- What is Rhythm Pharmaceuticals TTM net profit?
- What is the all time high TTM net income for Rhythm Pharmaceuticals?
- What is Rhythm Pharmaceuticals TTM net income year-on-year change?
What is Rhythm Pharmaceuticals annual net profit?
The current annual net income of RYTM is -$184.68 M
What is the all time high annual net income for Rhythm Pharmaceuticals?
Rhythm Pharmaceuticals all-time high annual net profit is -$11.07 M
What is Rhythm Pharmaceuticals annual net income year-on-year change?
Over the past year, RYTM annual net profit has changed by -$3.56 M (-1.97%)
What is Rhythm Pharmaceuticals quarterly net profit?
The current quarterly net income of RYTM is -$43.64 M
What is the all time high quarterly net income for Rhythm Pharmaceuticals?
Rhythm Pharmaceuticals all-time high quarterly net profit is $43.75 M
What is Rhythm Pharmaceuticals quarterly net income year-on-year change?
Over the past year, RYTM quarterly net profit has changed by +$522.00 K (+1.18%)
What is Rhythm Pharmaceuticals TTM net profit?
The current TTM net income of RYTM is -$258.91 M
What is the all time high TTM net income for Rhythm Pharmaceuticals?
Rhythm Pharmaceuticals all-time high TTM net profit is -$6.39 M
What is Rhythm Pharmaceuticals TTM net income year-on-year change?
Over the past year, RYTM TTM net profit has changed by -$73.37 M (-39.54%)